SC 13G Filing

Company

VYNE Therapeutics Inc.

Filed

August 13, 2018

Accession Number

0000930413-18-002569

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →